Literature DB >> 18474345

The synergism between atrial fibrillation and heart failure.

Melissa Byrne1, David M Kaye, John Power.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common comorbidity in heart failure (HF) patients and is classically associated with acceleration in the rate of HF progression. The precise mechanism for this interaction is unclear, but comprises "bidirectional" aspects in which AF promotes HF and HF also increases the likelihood of AF. We therefore studied the relationship between AF in an ovine model of pacing-induced congestive HF, in an attempt to identify the mechanisms that underpin the apparent synergistic relationship between AF and HF. METHODS AND
RESULTS: Sixteen adult sheep were paced at 190 beats/min for 21 days (HF). AF was induced in 8 of these animals at 14 days' pacing using programmed extrastimuli (HF + AF). Left ventricular hemodynamics and the pattern of cardiac neurohormonal activation, via coronary sinus (CS) sampling, were determined at rest and during submaximal exercise testing in both groups at 21 days and after AF reversion (by atrial defibrillation) at 21 days. CS norepinephrine (NE), endothelin (ET-1), and brain natriuretic peptide (BNP) levels were significantly increased in HF + AF animals, whereas LV end-diastolic pressure (EDP) and LV dP/dt max were significantly reduced compared with moderate HF alone. Cardioversion significantly reduced CS NE and BNP levels and improved contractility in AF + HF animals. In a further 6 animals, we explored the mechanism by which HF increases susceptibility to AF, with specific emphasis on the influence of functional mitral regurgitation. The elimination of MR in HF animals using a percutaneous mitral annular reduction device significantly decreased the inducibility of AF.
CONCLUSIONS: AF induction significantly depresses left ventricular function and causes activation of myocardial neurohormones. In conjunction, the presence of functional MR increases susceptibility to AF and this may be attenuated by MR reduction by percutaneous mitral annular reduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474345     DOI: 10.1016/j.cardfail.2007.12.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  8 in total

Review 1.  Atrial Fibrillation in Heart Failure-Diagnostic, Therapeutic, and Prognostic Relevance.

Authors:  Clara Stegmann; Gerhard Hindricks
Journal:  Curr Heart Fail Rep       Date:  2019-08

Review 2.  Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship.

Authors:  J C Caldwell; M A Mamas
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

4.  Functional transient receptor potential canonical type 1 channels in human atrial myocytes.

Authors:  Yan-Hui Zhang; Hui-Jun Wu; Hui Che; Hai-Ying Sun; Lik-Cheung Cheng; Xin Li; Wing-Kuk Au; Hung-Fat Tse; Gui-Rong Li
Journal:  Pflugers Arch       Date:  2013-05-19       Impact factor: 3.657

5.  Frailty Status Affects the Decision for Long-Term Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation.

Authors:  Panteleimon E Papakonstantinou; Natalia I Asimakopoulou; John A Papadakis; Dimitrios Leventis; Michail Panousieris; George Mentzantonakis; Ermis Hoda; Simeon Panagiotakis; Achilleas Gikas
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

6.  Abnormal mitochondrial L-arginine transport contributes to the pathogenesis of heart failure and rexoygenation injury.

Authors:  David Williams; Kylie M Venardos; Melissa Byrne; Mandar Joshi; Duncan Horlock; Nicholas T Lam; Paul Gregorevic; Sean L McGee; David M Kaye
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

7.  Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed AlTurki; Riccardo Proietti; Ahmed Dawas; Hasan Alturki; Thao Huynh; Vidal Essebag
Journal:  BMC Cardiovasc Disord       Date:  2019-01-15       Impact factor: 2.298

Review 8.  Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success.

Authors:  Kleiton Augusto Santos Silva; Craig A Emter
Journal:  JACC Basic Transl Sci       Date:  2020-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.